Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...

Stock-based compensation decreased by approximately $340 thousand in the three months ended September 30, 2024, compared to the three months ended September 30, 2023, primarily due to stock options ...

The chief executive of one of the U.S.’s largest legal cannabis companies said the big hit to cannabis stock this week isn’t ...

Operator Good morning and welcome to Ocugen's third quarter 2024 financial results and business update. [Operator ...

Orthofix Medical Inc (OFIX) reports a robust third quarter with significant revenue growth across key segments, despite ...

SBC Medical Group Holdings Incorporated, a global owner, operator and provider of management services and products to ...

The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...

While it is difficult to name a singular, cause of loneliness, it’s important to recognize the need and frequency for connection will look different for everyone. This means there is no quick fix, or ...

Analyst Michael Petusky of Barrington maintained a Buy rating on US Physical Therapy (USPH – Research Report), retaining the price target ...

MaxCyte now expects full year 2024 core business revenue of at least 5% growth compared to 2023. SPL Program-related revenue is expected to be approximately $6 million. The outlook for the full year ...

Vertex Pharmaceuticals continues to excel with strong Q3 results and promising clinical progress, but its valuation may ...

Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments.